Skip to main content

20 May 2022 by OXGENE


Download PDF – 4.1 MB

Viral vector delivery system is the most common form of genetic material delivering method for gene therapy. However, manufacture productivity and cost remains a considerable challenge of large-scale production of viral vectors. In this poster, we present the development of a robust suspension single clonal HEK293 cell line that can produce high titer and high quality AAV and lentiviral vector through plasmids transient transfection and TESSA technology for cGMP manufacturing.

Download the resource to continue reading.